An international honor headed to Houston's Dr John Mendelsohn, former president of MD
Anderson Cancer Center. It's called the Tang Prize in Biopharmaceutical Science...and
credits Mendelsohn for launching the field of targeted therapy that is now prolonging and
The award cites Dr Mendelsohn for leading the way in developing antibodies to block cancer
growth and applying it individually to patients. It has led to fundamentally changing the
practices of cancer clinics.
Think of it as great advancement in battling a world-wide scourge.
And he’s still in the fight. Dr Mendelsohn remains a professor in genomics and personalized
cancer treatment at MD Anderson and is a Senior Fellow at Rice University’s Baker Institute.